Cheri Walker

Chief Executive Officer at ATOMO DIAGNOSTICS LIMITED

Commercial Services

Health Technology

Finance

Profile

Cheri L.
Walker is currently Chief Executive Officer & Executive Director at Atomo Diagnostics Ltd. starting in 2026, Chief Executive Officer at Zeta Corp, and Director at Cell IDx, Inc. Former roles include President, Chief Executive Officer & Director at Rhinostics, Inc. from 2020 to 2023; Vice President at Invitrogen Corp.; Analyst at Deutsche Bank Securities, Inc. from 2003 to 2005; Senior Vice President-Corporate Development and Senior Vice President at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc.; Chief Commercial Officer at SeraCare Life Sciences, Inc.; Operating Executive at SFW Capital Partners LP; Vice President-Mergers & Acquisition at Qiagen, Inc. and QIAGEN Sciences, Inc.; and Vice President at Proteomics, Inc. Education includes undergraduate studies at Swarthmore College and a doctorate from Baylor College of Medicine.

Cheri Walker active positions

Companies	Position	Start
ATOMO DIAGNOSTICS LIMITED	Chief Executive Officer	19/08/2026
Cell IDx, Inc. Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services	Director/Board Member	-
Zeta Corp Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies	Chief Executive Officer	-

All active positions of Cheri Walker

Former positions of Cheri Walker

Companies	Position	End
Rhinostics, Inc. Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products	Chief Executive Officer	01/11/2023
Deutsche Bank Securities, Inc. Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	28/07/2005
SeraCare Life Sciences, Inc. SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry	Corporate Officer/Principal	-
Invitrogen Corp. Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services	Corporate Officer/Principal	-
Proteomics, Inc.	Corporate Officer/Principal	-

See the detail of Cheri Walker's experience

Training of Cheri Walker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cheri Walker's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Invitrogen Corp. Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services	Electronic Technology
Deutsche Bank Securities, Inc. Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Charles River Laboratories International, Inc. Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis	Commercial Services
Charles River Laboratories, Inc. Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research models and laboratory animal support services	Commercial Services
SeraCare Life Sciences, Inc. SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry	Health Technology
Swarthmore College Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Baylor College of Medicine Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SFW Capital Partners LP SFW Capital Partners LP Investment ManagersFinance SFW Capital Partners invests in companies located in the United States with a revenue of USD 10 - 100 million and EBITDA of USD 3 - 20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for MBOs, corporate carve-outs, recapitalizations and buyout, growth transactions with an investment size of USD 25 - 100 million. It acquires minority positions in the companies.	Finance
Qiagen, Inc. Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids	Commercial Services
QIAGEN Sciences, Inc. QIAGEN Sciences, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products	Process Industries
Proteomics, Inc.
Atomo Diagnostics Ltd. Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices	Health Technology
Cell IDx, Inc. Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services	Commercial Services
Rhinostics, Inc. Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products	Commercial Services
Zeta Corp Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies	Health Technology